Transforming Joint Infection Diagnostics

At Tricorian Life, we are pioneering the development of a cutting-edge diagnostic test for periprosthetic joint infections (PJIs). Our mission is to enhance patient outcomes, lower healthcare costs, and establish new global benchmarks in diagnostic accuracy. Through a commitment to regulatory compliance, strategic partnerships, and a well-defined implementation strategy, Tricorian Life is poised to transform the landscape of healthcare diagnostics. This presents a unique and impactful opportunity for investors to contribute to a groundbreaking advancement in diagnostics.

Learn more about our mission:

About us

Navigating Diagnostic Limitations and Risks Before and After Implant Surgery

The Challenge - Joint Infections

Orthopaedic infections, particularly Periprosthetic Joint Infections (PJI), pose significant challenges to healthcare systems worldwide. Current diagnostic methods are time-consuming, often inaccurate, and lead to substantial patient morbidity and healthcare costs. The orthopaedic community urgently needs innovative solutions to address these critical issues:

Slow Diagnosis

Traditional culture methods are slow, often taking up to 15 days to yield results, which can lead to delayed treatment and increased risk of misdiagnosis.

Diagnostic Uncertainty

With no definitive test for PJI and highly variable sensitivity (65-94%) of tissue cultures, many infections go undetected or are misdiagnosed, leading to significant challenges in accurate diagnosis and treatment.

Economic Burden

The average cost of treating a Surgical Site Infection (SSI) in Australia is estimated to exceed A$18,000 per case, highlighting the substantial financial burden on the healthcare system.

Prevalence and Under-reporting

Approximately 3% of orthopaedic surgeries lead to infections, with 76% of SSIs detected post-discharge. However, accurate figures are challenging to determine, as an estimated 63% of these infections may go unreported.

What Are We Doing About It?

Innovative Molecular Techniques for Faster, Precise Detection in Synovial Fluid

We are leveraging advanced molecular diagnostic techniques to develop solutions that can provide quicker, more accurate results for the detection of pathogens in synovial fluid. Our goal is to enable timely decisions that improve patient outcomes.

Innovative Detection Approach

Utilizing advanced PCR technology to accurately and quickly diagnose joint infections from synovial fluid.

Clinician Collaboration

Created in close collaboration with orthopaedic surgeons, ensuring the diagnostic solutions align with the practical demands of surgical practices to enhance patient outcomes.

Global Accessibility

Engineered for compatibility with multiple PCR platforms, ensuring broad access and scalability across diverse healthcare environments.

Rigorous Validation Commitment

Dedicated to meeting the highest standards, we are conducting extensive clinical validation to secure phased regulatory approvals and facilitate market entry.